Logo

Wendy Britten

Aug 28, 2018

Congenica has named Wendy Britton chief financial officer, effective Sept. 1. Britten joins the British clinical genomics interpretation software vendor from AstraZeneca, where she led group finance business performance. In addition to the normal CFO responsibilities, Britten will have a say in Congenica's business development and future fundraising, the company said. In announcing Britten's hiring, Congenica disclosed that it raised $13.5 million in a Series B that concluded in April 2017, higher than the $10 million reported two months earlier.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.